Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

被引:11
作者
Jiang, YongWei [1 ]
Ma, Liang [2 ,3 ]
Han, ChengWu [1 ]
Liu, Qian [1 ]
Cong, Xiao [1 ]
Xu, YaPing [4 ]
Zhao, TingTing [3 ]
Li, Ping [2 ,3 ]
Cao, YongTong [1 ]
机构
[1] China Japan Friendship Hosp, Clin Lab, Beijing, Peoples R China
[2] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Inst Clin Med Sci, Dept Pathophysiol, Beijing, Peoples R China
关键词
E GENE POLYMORPHISM; RENAL-DISEASE; APOE POLYMORPHISM; KIDNEY-DISEASE; ASSOCIATION; PROGRESSION; MELLITUS; SUSCEPTIBILITY; POPULATION; METABOLISM;
D O I
10.1155/2017/3560920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group (n = 429) and control group (n = 416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences (P < 0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE epsilon 2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41-3.47, and P < 0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, P < 0.05). The ApoE epsilon 4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50-0.97, and P < 0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96% P < 0.05). These results suggest ApoE epsilon 2 allele may be a risk factor; however ApoE epsilon 4 allele may play a protective role of DN in Chinese type 2 diabetic patients.
引用
收藏
页数:6
相关论文
共 32 条
[1]   APOE polymorphism and diabetic nephropathy [J].
Araki, Shin-ichi .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) :230-233
[2]   ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? [J].
Boize, R ;
Benhamou, PY ;
Corticelli, P ;
Valenti, K ;
Bosson, JL ;
Halimi, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) :72-75
[3]   A protective role for kidney apolipoprotein E - Regulation of mesangial cell proliferation and matrix expansion [J].
Chen, GP ;
Paka, L ;
Kako, Y ;
Singhal, P ;
Duan, WL ;
Pillarisetti, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49142-49147
[4]   INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-B-100 METABOLISM IN NORMOLIPEMIC SUBJECTS [J].
DEMANT, T ;
BEDFORD, D ;
PACKARD, CJ ;
SHEPHERD, J .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1490-1501
[5]   The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 diabetic patients with and without nephropathy [J].
Erdogan, M. ;
Eroglu, Z. ;
Biray, C. ;
Karadeniz, M. ;
Cetinkalp, S. ;
Kosova, B. ;
Gunduz, C. ;
Topcuoglu, N. ;
Ozgen, G. ;
Yilmaz, C. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (03) :219-222
[6]  
Eto M, 1995, CLIN GENET, V48, P288
[7]   Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients [J].
Eto, M ;
Saito, M ;
Okada, M ;
Kume, Y ;
Kawasaki, F ;
Matsuda, M ;
Yoneda, M ;
Matsuki, M ;
Takigami, S ;
Kaku, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :243-251
[8]   Frequencies of apolipoprotein A4 gene polymorphisms and association with serum lipid concentrations in two healthy Spanish populations [J].
Gañán, A ;
Corella, D ;
Guillén, M ;
Ordovás, JM ;
Pocoví, M .
HUMAN BIOLOGY, 2004, 76 (02) :253-266
[9]   Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus [J].
Ha, SK ;
Park, HS ;
Kim, KW ;
Kim, SJ ;
Kim, DH ;
Kim, JH ;
Lee, HY ;
Han, DS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2144-2149
[10]   APOLIPOPROTEIN E2, RENAL-FAILURE AND LIPID ABNORMALITIES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HORITA, K ;
ETO, M ;
MAKINO, I .
ATHEROSCLEROSIS, 1994, 107 (02) :203-211